Literature DB >> 29844245

Sex-Specific Versus Overall Clinical Decision Limits for Cardiac Troponin I and T for the Diagnosis of Acute Myocardial Infarction: A Systematic Review.

Dorien M Kimenai1,2, Emma B N J Janssen1, Kai M Eggers3, Bertil Lindahl4, Hester M den Ruijter5, Otto Bekers1,2, Yolande Appelman6, Steven J R Meex7,2.   

Abstract

BACKGROUND: The overall clinical decision limits of high-sensitivity cardiac troponin I (hs-cTnI; 26 ng/L) and T (hs-cTnT; 14 ng/L) may contribute to underdiagnosis of acute myocardial infarction in women. We performed a systematic review to investigate sex-specific and overall 99th percentiles of hs-cTnI and hs-cTnT derived from healthy reference populations. CONTENT: We searched in PubMed and EMBASE for original studies, and by screening reference lists. Reference populations designed to establish 99th percentiles of hs-cTnI (Abbott) and/or hs-cTnT (Roche), published between January 2009 and October 2017, were included. Sex-specific and overall 99th percentile values of hs-cTnI and hs-cTnT were compared with overall clinical decision ranges (hs-cTnI, 23-30 ng/L; hs-cTnT, 13-25 ng/L). Twenty-eight studies were included in the systematic review. Of 16 hs-cTnI and 18 hs-cTnT studies, 14 (87.5%) and 11 (61.1%) studies reported lower female-specific hs-cTn cutoffs than overall clinical decision ranges, respectively. Conversely, male-specific thresholds of both hs-cTnI and hs-cTnT were in line with currently used overall thresholds, particularly hs-cTnT (90% concordance). The variation of estimated overall 99th percentiles was much higher for hs-cTnI than hs-cTnT (29.4% vs 80.0% of hs-cTnI and hs-cTnT studies reported values within the current overall clinical decision range, respectively).
SUMMARY: Our data show substantially lower female-specific upper reference limits of hs-cTnI and hs-cTnT than overall clinical decision limits of 26 ng/L and 14 ng/L, respectively. The statistical approach strongly affects the hs-cTnI threshold. Downward adjustment of hs-cTn thresholds in women may be warranted to reduce underdiagnosis of acute myocardial infarction in women.
© 2018 American Association for Clinical Chemistry.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29844245     DOI: 10.1373/clinchem.2018.286781

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  11 in total

1.  Distribution of High-Sensitivity Cardiac Troponin and N-Terminal Pro-Brain Natriuretic Peptide in Healthy Transgender People.

Authors:  Dina N Greene; Robert L Schmidt; Robert H Christenson; Jessica Rongitsch; Katherine L Imborek; Heather Rebuck; Thomas S Lorey; Amy K Saenger; Matthew D Krasowski
Journal:  JAMA Cardiol       Date:  2022-10-05       Impact factor: 30.154

2.  Risk factors for type 1 and type 2 myocardial infarction.

Authors:  Ryan Wereski; Dorien M Kimenai; Anda Bularga; Caelan Taggart; David J Lowe; Nicholas L Mills; Andrew R Chapman
Journal:  Eur Heart J       Date:  2022-01-13       Impact factor: 35.855

3.  Sex-specific effects of implementing a high-sensitivity troponin I assay in patients with suspected acute coronary syndrome: results from SWEDEHEART registry.

Authors:  Dorien M Kimenai; Bertil Lindahl; Tomas Jernberg; Otto Bekers; Steven J R Meex; Kai M Eggers
Journal:  Sci Rep       Date:  2020-09-17       Impact factor: 4.379

4.  High-sensitivity troponin in the evaluation of patients with suspected acute coronary syndrome: a stepped-wedge, cluster-randomised controlled trial.

Authors:  Anoop S V Shah; Atul Anand; Fiona E Strachan; Amy V Ferry; Kuan Ken Lee; Andrew R Chapman; Dennis Sandeman; Catherine L Stables; Philip D Adamson; Jack P M Andrews; Mohamed S Anwar; John Hung; Alistair J Moss; Rachel O'Brien; Colin Berry; Iain Findlay; Simon Walker; Anne Cruickshank; Alan Reid; Alasdair Gray; Paul O Collinson; Fred S Apple; David A McAllister; Donogh Maguire; Keith A A Fox; David E Newby; Christopher Tuck; Ronald Harkess; Richard A Parker; Catriona Keerie; Christopher J Weir; Nicholas L Mills
Journal:  Lancet       Date:  2018-08-28       Impact factor: 79.321

Review 5.  The Biomarkers for Acute Myocardial Infarction and Heart Failure.

Authors:  Xi-Ying Wang; Fen Zhang; Chi Zhang; Liang-Rong Zheng; Jian Yang
Journal:  Biomed Res Int       Date:  2020-01-17       Impact factor: 3.411

Review 6.  Acute coronary syndromes.

Authors:  Brian A Bergmark; Njambi Mathenge; Piera A Merlini; Marilyn B Lawrence-Wright; Robert P Giugliano
Journal:  Lancet       Date:  2022-04-02       Impact factor: 79.321

7.  High-Sensitivitycardiac Troponinsin Cardio-Healthy Subjects: A Cardiovascular Magnetic Resonance Imaging Study.

Authors:  Tar-Choon Aw; Wei-Ting Huang; Thu-Thao Le; Chee-Jian Pua; Briana Ang; Soon-Kieng Phua; Khung-Keong Yeo; Stuart A Cook; Calvin W L Chin
Journal:  Sci Rep       Date:  2018-10-18       Impact factor: 4.379

8.  Sex-Specific Thresholds of High-Sensitivity Troponin in Patients With Suspected Acute Coronary Syndrome.

Authors:  Kuan Ken Lee; Amy V Ferry; Atul Anand; Fiona E Strachan; Andrew R Chapman; Dorien M Kimenai; Steven J R Meex; Colin Berry; Iain Findlay; Alan Reid; Anne Cruickshank; Alasdair Gray; Paul O Collinson; Fred S Apple; David A McAllister; Donogh Maguire; Keith A A Fox; David E Newby; Chris Tuck; Catriona Keerie; Christopher J Weir; Anoop S V Shah; Nicholas L Mills
Journal:  J Am Coll Cardiol       Date:  2019-10-22       Impact factor: 24.094

Review 9.  Implementing an early rule-out pathway for acute myocardial infarction in clinical practice.

Authors:  Matthew T H Lowry; Atul Anand; Nicholas L Mills
Journal:  Heart       Date:  2021-09-03       Impact factor: 5.994

10.  Sex Differences in Cardiac Troponin I and T and the Prediction of Cardiovascular Events in the General Population.

Authors:  Dorien M Kimenai; Anoop S V Shah; David A McAllister; Kuan Ken Lee; Athanasios Tsanas; Steven J R Meex; David J Porteous; Caroline Hayward; Archie Campbell; Naveed Sattar; Nicholas L Mills; Paul Welsh
Journal:  Clin Chem       Date:  2021-10-01       Impact factor: 12.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.